Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2025)

Historic Tax Rate for Neurocrine Biosciences (NBIX) over the last 6 years, with Q4 2025 value amounting to 35.8%.

  • Neurocrine Biosciences' Tax Rate fell 8000.0% to 35.8% in Q4 2025 from the same period last year, while for Dec 2025 it was 32.15%, marking a year-over-year increase of 23800.0%. This contributed to the annual value of 32.15% for FY2025, which is 23800.0% up from last year.
  • Neurocrine Biosciences' Tax Rate amounted to 35.8% in Q4 2025, which was down 8000.0% from 28.2% recorded in Q3 2025.
  • Over the past 5 years, Neurocrine Biosciences' Tax Rate peaked at 46.26% during Q1 2025, and registered a low of 25.8% during Q1 2024.
  • For the 4-year period, Neurocrine Biosciences' Tax Rate averaged around 23.67%, with its median value being 28.11% (2023).
  • Its Tax Rate has fluctuated over the past 5 years, first plummeted by -516400bps in 2024, then soared by 720600bps in 2025.
  • Over the past 4 years, Neurocrine Biosciences' Tax Rate (Quarter) stood at 26.23% in 2021, then decreased by -3bps to 25.48% in 2023, then soared by 44bps to 36.59% in 2024, then dropped by -2bps to 35.8% in 2025.
  • Its last three reported values are 35.8% in Q4 2025, 28.2% for Q3 2025, and 32.6% during Q2 2025.